LivaNova PLC (NASDAQ:LIVN) shares were down 1.6% during mid-day trading on Monday . The stock traded as low as $49.33 and last traded at $49.37, with a volume of 237,016 shares. The stock had previously closed at $50.19.

Separately, Piper Jaffray Cos. restated an “overweight” rating and set a $59.00 target price (down previously from $61.00) on shares of LivaNova PLC in a report on Thursday, July 7th. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $66.25.

The firm’s market cap is $2.46 billion. The company has a 50 day moving average of $49.46 and a 200 day moving average of $52.79.

In related news, Director Alfred J. Novak sold 4,000 shares of the business’s stock in a transaction on Friday, May 6th. The stock was sold at an average price of $51.12, for a total value of $204,480.00. Following the completion of the sale, the director now directly owns 13,020 shares in the company, valued at approximately $665,582.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Hugh M. Morrison sold 3,600 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $48.00, for a total value of $172,800.00. Following the completion of the sale, the director now owns 5,215 shares of the company’s stock, valued at $250,320. The disclosure for this sale can be found here.

A number of hedge funds have recently added to or reduced their stakes in LIVN. Fernwood Investment Management LLC purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,032,000. First Trust Advisors LP purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,134,000. State Board of Administration of Florida Retirement System purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,390,000. Comerica Bank purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,542,000. Finally, FOURPOINTS Investment Managers S.A.S. purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,964,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.